NCT03657251: MMRF CureCloud Research Initiative
Updated: Feb 10
NCT03657251: MMRF CureCloud Research Initiative
NDMM
RRMM
MGUS/SMM
MMRF CureCloud Research Initiative
Observational Study
The MMRF CureCloud Research Initiative, a Direct-to-Patient Research effort aimed at enrolling 5,000 individuals from whom comprehensive molecular and immune analyses will be generated from blood specimens and the resulting data aggregated with the correlating clinical information. Blood will be collected from all participants after electronic online consenting via a mailed blood kit designed for a mobile phlebotomy appointment. Through the consenting process, participants will also be authorizing linkage to their electronic medical records information.
Sponsor:Multiple Myeloma Research Foundation
Genetic: liquid biopsy
ClinicalTrials.gov Identifier: NCT03657251
Official Title: The MMRF CureCloud Multiple Myeloma Research Initiative
First Posted : September 5, 2018
Click here for details on ClinicalTrials.gov
Patients that have been diagnosed with Multiple Myeloma, or one of its precursor conditions to share their clinical information and blood samples to help scientists and researchers understand these conditions better.
The study will use submitted blood samples to perform comprehensive research that will include, among others, genomic and immune characterization, as well as collect past and present medical records to combine and compare with the blood sample analysis.
Learn more: https://mmrfcurecloud.org/
Welcome to the MMRF CureCloud!
Multiple Myeloma Research Foundation
NCT01454297: MMRF CoMMpass Study in Newly Diagnosed Multiple Myeloma - (CoMMpass)
United States, Massachusetts
- Massachusetts: Dana-Farber Cancer Institute/Harvard Cancer Center Boston